| |
| |
|
| Insider
Information: |
Fromkin Drew J |
| Relationship: |
Director |
| City: |
Newton |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
99,913 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
99,913 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Clinical Data Inc |
CLDA |
CEO, President, Director |
2011-04-12 |
0 |
2006-08-21 |
0 |
Premium* |
|
|
Tobira Therapeutics Inc |
TBRA |
Director |
2016-11-01 |
0 |
2016-11-01 |
0 |
Premium* |
|
|
Immunovant Inc |
IMVT |
Director |
2024-04-02 |
99,913 |
2020-05-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
21 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IMVT |
Immunovant Inc |
Director |
– • – |
2024-04-02 |
4 |
A |
$0.00 |
$0 |
D/D |
11,255 |
99,913 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Director |
– • – |
2023-12-01 |
4 |
AS |
$38.78 |
$490,697 |
D/D |
(12,350) |
88,658 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Director |
– • – |
2023-04-12 |
4 |
A |
$0.00 |
$0 |
D/D |
12,523 |
101,008 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Director |
– • – |
2022-08-17 |
4 |
A |
$0.00 |
$0 |
D/D |
21,059 |
88,485 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Director |
– • – |
2022-01-10 |
4 |
A |
$0.00 |
$0 |
D/D |
21,726 |
67,426 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Director |
– • – |
2021-08-10 |
4 |
B |
$7.90 |
$43,450 |
D/D |
5,500 |
45,700 |
2.39 |
- |
|
| IMVT |
Immunovant Inc |
Director |
– • – |
2021-03-19 |
4 |
A |
$0.00 |
$0 |
D/D |
15,500 |
40,200 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Director |
– • – |
2020-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
24,700 |
24,700 |
0 |
- |
|
| TBRA |
Tobira Therapeutics Inc |
Director |
– • – |
2016-11-01 |
4 |
D |
$0.00 |
$0 |
I/I |
(5) |
0 |
0 |
- |
|
| TBRA |
Tobira Therapeutics Inc |
Director |
– • – |
2016-11-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(11) |
0 |
0 |
- |
|
| TBRA |
Tobira Therapeutics Inc |
Director |
– • – |
2014-06-12 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
50 |
|
- |
|
| TBRA |
Tobira Therapeutics Inc |
Director |
– • – |
2014-06-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
100 |
|
- |
|
| CLDA |
Clinical Data Inc |
CEO, President |
• • – |
2011-04-12 |
4 |
D |
$30.00 |
$282,150 |
D/D |
(9,405) |
0 |
0 |
- |
|
| CLDA |
Clinical Data Inc |
CEO, President |
• • – |
2008-11-12 |
4 |
B |
$9.56 |
$19,130 |
D/D |
2,000 |
9,405 |
2.81 |
- |
|
| CLDA |
Clinical Data Inc |
CEO, President |
• • – |
2008-09-02 |
4 |
OE |
$15.00 |
$30,000 |
D/D |
2,000 |
7,405 |
0 |
- |
|
| CLDA |
Clinical Data Inc |
CEO, President |
• • – |
2007-12-12 |
4 |
B |
$22.77 |
$42,931 |
D/D |
1,880 |
4,230 |
2.81 |
- |
|
| CLDA |
Clinical Data Inc |
CEO, President |
• • – |
2007-12-12 |
4/A |
B |
$22.77 |
$42,931 |
D/D |
1,880 |
5,405 |
2.81 |
- |
|
| CLDA |
Clinical Data Inc |
CEO, President |
• • – |
2007-09-06 |
4 |
B |
$26.70 |
$32,034 |
D/D |
1,200 |
2,350 |
2.81 |
- |
|
| CLDA |
Clinical Data Inc |
CEO, President |
• • – |
2006-12-11 |
4 |
B |
$16.67 |
$10,837 |
D/D |
650 |
1,150 |
2.81 |
- |
|
| CLDA |
Clinical Data Inc |
CEO, President |
• – – |
2006-08-21 |
4/A |
B |
$11.90 |
$5,950 |
D/D |
500 |
500 |
2.74 |
- |
|
| CLDA |
Clinical Data Inc |
CEO, President |
• – – |
2006-08-21 |
4 |
A |
$11.90 |
$5,950 |
D/D |
500 |
500 |
|
- |
|
21 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
